부산대학교 도서관

This article provides an overview of the development and future of automated insulin delivery (AID) systems, which include insulin pumps, continuous glucose monitoring (CGM), and smart algorithms. It discusses the advancements in insulin pump technology, from the first portable pump in 1963 to the smaller, wearable pumps introduced in the 1980s and beyond. The article also explores the integration of CGM with insulin pumps and the introduction of AID systems that automatically deliver insulin based on real-time glucose data. It highlights specific AID systems, such as the MiniMed™ 670G and 780G, and the t:slim X2™ with Control-IQ technology. The document further provides an overview of various artificial pancreas systems for the management of type 1 diabetes (T1D), including the Tandem AHCL Control-IQ, OmniPod 5 HCL, Diabeloop generation 1, CamAPS FX, Tidepool Loop, and Beta Bionics iLet. It discusses the results of clinical trials and real-world data for these systems and addresses barriers to adoption, such as cost and user experience. The article concludes that the use of artificial pancreas systems improves glucose control and reduces the burden of diabetes, with the potential to prevent long-term complications. [Extracted from the article]